How far are we away from a Star-Trek-like device that can analyze a lesion and assess its malignancy? We review the main challenges in this field in light of the Blois paradigm of clinical judgment and computers.
OVERVIEW
The Machine as a Diagnostic Adjunct: Limiting the Cognitive Span
Clinical Cognitive Span: The Blois Paradigm
In the New England Journal of Medicine, Dr. M. Scott Blois discussed the role of computers in the clinic (Blois, 1980) . The Blois paradigm states that computers perform best using 'low level' information derived from physical or chemical measurements, and perform worst using 'high level' information, such as patient statements. When a doctor first sees a patient in the examination room, there is a wide range of possible diagnoses.
Complicating the case is the interaction between diagnoses that make the problem more complex. Symptoms may be embellished or diminished. A skilled clinician can adroitly navigate this subjective information, separating benign conditions from harmful conditions-the paramount diagnostic challenge in medicine. The complexity is high during the initial clinic visit, where visual and verbal information is unsorted and the range of possibilities, which Blois termed the 'cognitive span,' is wide (point A, Figure  1 ). Further into the evaluation, we may have chemical or physical information, e.g. blood samples (point B, Figure 1 ). Humans function best with the subjective information at point A, and computers function best at point B, once the cognitive span is narrowed. Where do we place image analysis in this scheme, at point A, requiring human assessment, at point B, or somewhere in between? With recent developments, image analysis is still between points A and B, but has moved closer to point B. In this paper, we review several factors that have allowed this advancement in computer image analysis. New image analysis techniques, new data fusion techniques that combine clinical and image information, and new uses of classifiers have allowed advancements in the application of computer vision that have increased computer accuracy in diagnosing skin lesions.
Defining the Problem: Is This
Lesion a Skin Cancer, or Do I Have a Skin Cancer Anywhere?
Most skin cancer detection research focuses on the constrained problem: is this lesion a melanoma? In Blois' paradigm, at point A, the patient wants to know: "Is there a skin cancer present anywhere on my skin?" But research has been focused on the narrower problem that is closer to point B: "Given a single lesion, is this lesion a melanoma?" So we ask: "Are there tools that could help us bridge this gap, getting us from point A to point B?". For decades, total-body photography has been used to assess the skin surface and detect changes (Slue et al., 1988) Melanoscan still requires the manual comparison of images taken at different times to detect changes. Recent advances in image registration can further automate this process. We now have quantitative information supporting Melanoscan's effectiveness in detecting melanomas at an earlier stage. During the course of a study of melanoma in situ , the Melanoscan clinic detected a higher percentage of melanomas at the in situ stage ( Figure  3 ). This represents progress toward answering the more general question about having a melanoma anywhere, with the possibility of detecting any changes in skin cancer anywhere. The societal burden of invasive melanoma is significant. A measure of impact is the average number of years of life lost (AYLL) caused by the disease. The AYLL to melanoma is 23 years (Burnet et al., 2005) . Melanoma ranks 4th among all cancers for AYLL/mortality (Salama et al., 2012) , making it one of four 'Cinderella cancers,' (along with brain, uterine, and cervical) for which research, treatment, and diagnostic advancements are significantly lower than expected for the AYLL.
Importance of Non-Melanoma Skin Cancer
To the societal burden of melanoma, we may add 3.5 million estimated cases of non-melanoma skin cancer (NMSC) in the USA, that are annually responsible for over 2,000 deaths per year (Bickers et al., 2006) . Economic costs of these skin cancers exceed $2 billion in the USA, alone. Only scant research has been done on automated NMSC detection, which is now an area that could greatly benefit from the effective application of computer vision techniques ; .
New Problem: Detecting a 2mm Melanoma
During the 1990s, a group of researchers in Italy and Austria gathered a large collection of dermoscopy images of melanoma and benign lesions (Argenziano et al., 2000) . These advanced lesions had features allowing high diagnostic accuracy in automatic systems, with two reports showing 95-96% diagnostic accuracy (Stanley et al., 2005) , (Wadhawan et al., 2011) . Recently, the automatic diagnosis problem has become more difficult with earlier and smaller lesions, such as the 2mm melanoma in a 48-year-old (Fig. 4) .
Economic Burden of Benign Lesions
In dermatology clinics, the most common tumor is a benign lesion called a "seborrheic keratosis." These dark, fast-growing lesions alarm patients when they first appear. Dermoscopy changes everything, because it shows benign features with greater clarity. Little research has been done to identify these common lesions, which can be recognizing features such as milia-like cysts (Stricklin et al., 2011) . 
IMAGE BORDERS AND ARTIFACTS

The Main Unsolved Computer Vision Problems: Borders and Artifacts
Automatic segmentation of skin cancer borders would seem to be an easy task, yet the problem remains unsolved. One leading technique applied to these complex images is minimal energy contours (Caselles et al., 1997) . Hair removal, or hair segmentation, is an essential part of image processing, because hair mimics critical melanoma features. Figure 5 shows an example of hair removal from a dermoscopic image. The anisotropic diffusion method of edge detection is employed to accurately identify hair segments (Perona and Malik, 1990) . Although this method is capable of segmenting a majority of hairs, it is prone to producing noise in the form of non-hair areas. Morphological noise removal techniques are then used to remove these non-hair segments. 
ANTHROPOMORPHISM IN IMAGE ANALYSIS
Innovation in computer vision can start with an insight from human experience. Using the computer vision technique "anthropomorphism," we train the computer to see objects that humans can see. To detect amelanotic melanoma, the difficult variant lacking pigment, we mimicked the observation of Menzies, who noted that amelanotic melanoma has more than one shade of pink (Menzies et al., 2008 ). Yet the computers need a way to separate melanoma pink from benign pink. We therefore analyzed a different set of lesions-melanomas and benign mimics having pink areas. We studied pink shade and location variants, finding that location outweighs shade. Using the anthropomorphic finding that locations and shades of pink are germane, we found varied shades of pink and used the distance transform to overlay concentric quintiles on these shades (Figure 6 ). Calculating color, texture and blob features in detected pink areas has yielded a high diagnostic accuracy in preliminary research. Thus, the anthropomorphic technique can provide useful feature measurement for detecting skin cancer.
EARLIEST DETECTABLE CHANGES IN MELANOMA: ATYPICAL PIGMENT NETWORK
An atypical pigment network (APN) is a critical feature for successfully classifying melanoma. Clinical APN presence yields an odds ratio of 9.0 for melanoma (Argenziano et al., 2003) . Figure 7 shows the steps for automatic APN detection, which is used as classifier inputs to predict malignancy. This technique was successful in finding APN in the 2mm melanoma in Fig. 4 .
DATA FUSION AND THE BLOIS PARADIGM
The tiny melanoma presented earlier was diagnosed when we added clinical information, specifically, the patient's concern and observation of lesion change. A logistic regression analysis on 885 pigmented lesions shows that the two features with the highest Chi-square significance are clinical features: the patient's age and concern about the lesion, allowing diagnosis of these images by clinical information alone. Data fusion using clinical and skin lesion image information has been shown to improve lesion discrimination by 19.9% over clinical and image information only, while image features yield higher lesion discrimination than clinical features by as much as 9.7% (Cheng et al., 2012) .
DIAGNOSTIC ASSISTANT IN THE CLINIC
We have presented advances that further the goal of automatic detection of skin cancer. The US Food and Drug Administration noted the need to include critical patient information in devices to maximize diagnostic accuracy. Thus, even the early lesions showing up more commonly in the clinic can now be diagnosed. The path to success from research to clinic should focus on the patient-centered problem, "Do I have a skin cancer?" For the best patient acceptance of automatic devices, assessment of lesion change and non-melanoma skin cancers, as well as benign melanoma mimics, should be included in the research agenda of the computer vision community.
